Skip to content


Journal of Circadian Rhythms

Open Access

Wildtype epidermal growth factor receptor (Egfr) is not required for daily locomotor or masking behavior in mice

Journal of Circadian Rhythms20064:15

Received: 20 October 2006

Accepted: 16 November 2006

Published: 16 November 2006



Recent studies have implicated the epidermal growth factor receptor (EGFR) within the subparaventricular zone as being a major mediator of locomotor and masking behaviors in mice. The results were based on small cohorts of mice homozygous for the hypomorphic Egfr wa2 allele on a mixed, genetically uncontrolled background, and on intraventricular infusion of exogenous EGFR ligands. Subsequenlty, a larger study using the same genetically mixed background failed to replicate the original findings. Since both previous approaches were susceptible to experimental artifacts related to an uncontrolled genetic background, we analyzed the locomotor behaviors in Egfr wa2 mutant mice on genetically defined, congenic backgrounds.


Mice carrying the Egfr wa2 hypomorphic allele were bred to congenicity by backcrossing greater than ten generations onto C57BL/6J and 129S1/SvImJ genetic backgrounds. Homozygous Egfr wa2 mutant and wildtype littermates were evaluated for defects in locomotor and masking behaviors.


Mice homozygous for Egfr wa2 showed normal daily locomotor activity and masking indistinguishable from wildtype littermates at two light intensities (200–300 lux and 400–500 lux).


Our results demonstrate that reduced EGFR activity alone is insufficient to perturb locomotor and masking behaviors in mice. Our results also suggest that other uncontrolled genetic or environmental parameters confounded previous experiments linking EGFR activity to daily locomotor activity and provide a cautionary tale for genetically uncontrolled studies.


The epidermal growth factor receptor (EGFR) pathway plays key roles in the development and maintenance of many tissue and organ systems [1]. Recent reports have suggested that the EGFR pathway mediates two aspects of behavior, diurnal locomotor activity and suppression of locomotion in response to light (masking). Levels of the EGFR ligand transforming growth factor alpha (TGFA) fluctuate with a circadian rhythm within the suprachiasmatic nucleus (SCN) [2, 3], which is located within the hypothalamus and is considered the primary anatomical circadian clock, and are associated with circadian time-dependent changes in gene expression [4]; similarly, EGFR ligands are expressed within cells of the retina, which modulates masking behavior [3]. Both of these structures appear to input into the subparaventricular zone (SPZ), a hypothalamic region that is required for circadian rhythms [5] and that expresses high levels of EGFR [3]. This anatomical network has been experimentally manipulated, with infusion of TGFA into the hamster hypothalamus reversibly suppressing locomotor activity [3, 6]. However, exogenous administration of receptor ligands can lead to non-physiological responses, indicating what a protein can do, not necessarily its normal biological function [7].

Perhaps the most compelling evidence implicating the EGFR pathway in locomotor activity and masking was found in the behavior of mice homozygous for the Egfr wa2 allele, which produces a hypomorphic receptor with reduced kinase activity [8, 9]. The Egfr wa2 allele is a valuable genetic reagent for dissecting biological functions of EGFR since homozygosity for Egfr null alleles results in lethality [1, 10], while Egfr wa2 homozygous animals can survive to adulthood. Both abnormally high diurnal activity and strong masking defects were reported in four of five B6EiC3H-a/A-Egfr wa2/wa2 Wnt3a vt/vt mice tested [3]. Conflicting with these observations, a larger study using a greater number of mice from the same source (The Jackson Laboratory) and a range of illumination intensities did not detect any masking defects [11].

Previous analyses investigating alterations in locomotor and masking behaviors used mice carrying the Egfr wa2 allele on a mixed genetic background. In order to resolve the discrepancies implicating a critical role for EGFR in locomotor and masking behaviors, as well as to examine potential genetic background effects on these defects, we tested Egfr wa2 homozygotes on uniform congenic or hybrid backgrounds for locomotor activity and masking ability. The current results conclusively demonstrate that EGFR is not an essential mediator of locomotor or masking behaviors and suggests that other uncontrolled genetic or environmental parameters confounded previous experiments.


B6EiC3H-a/A-Egfr wa2/wa2 Wnt3a vt/vt mice were obtained from The Jackson Laboratory (Bar Harbor, ME). The derivation of the Egfr wa2 congenic lines involved backcrossing the Egfr wa2 allele for greater than ten generations to C57BL/6J and 129S1/SvImJ genetic backgrounds. The removal of the linked Wnt3a vt hypomorphic allele, maintained in cis with Egfr wa2 in the initial starting population, was verified by PCR-based genotyping. Mice were given at least one week to acclimate to their new environment prior to testing. Mice were provided PicoLab Mouse Diet 20 (LabDiet) ad libitum and autoclaved water.

Mice were housed singly and habituated several days in cages equipped with running wheels for activity measurements, within a light-tight box containing a cool-white fluorescent tube providing 200 to 300 lux or 400 to 500 lux light at cage level on a 12 h:12 h light-dark cycle. Diurnal activity was calculated as the percentage of total activity occurring in the light phase of the cycle. For the masking response analysis, either one or three hour light pulses were delivered on the third day starting at Zeitgeber Time (ZT) 14 (ZT0 = light on; ZT12 = lights off). Each animal was tested for masking to two or three light pulses with at least two days between pulses. Activity during the pulse was calculated as a percentage of the activity at the same time on the previous day. Locomotor activity was recorded and analyzed with ClockLab software (Actimetrics, Evanston, IL).

Results and discussion

Mice with normal light-mediated locomotor activity generally have one to two percent daytime activity, and masking of greater than 95%. An initial round of testing utilized commonly administered conditions, one-hour light pulses at 400–500 lux, to determine masking response. Of the six animals tested, none showed a masking defect, and only a single animal, an Egfr wa2/wa2 Wnt3a vt/vt mouse on a mixed genetic background similar to those previously used [3], demonstrated higher than normal diurnal activity (data not shown).

A larger panel of mice was then tested using three-hour light pulses at 200–300 lux, conditions identical to those of the previous study reporting Egfr wa2-associated abnormalities [3]. Surprisingly, the vast majority of Egfr wa2 homozygous mice exhibited both normal daytime activity and negative masking, as did all wild-type littermates and a C57BL/6J-Wnt3a vt/vt mouse (Table 1). Indeed, no statistically significant differences were found when the data were grouped by Egfr status (one-way ANOVA: % daytime activity, p = 0.32; % masking, p = 0.27; total activity (rev), p = 0.49). Two Egfr wa2/wa2 mice, one male C57BL/6J-Egfr wa2/wa2 and one female B6.129 F1-Egfr wa2/wa2, exhibited both abnormal daytime activity and negative masking defects similar, but not as extreme, as those previously described [3]. Unlike what happened in the previous study, the majority of the abnormally high daytime activity seen in the two affected mice was not sporadic, but rather occurred in a discrete time period anticipating the dark cycle and thus resulting in a consistent phase shift (Fig. 1A). Similar to the previous study, the negative masking in mice was delayed, with normal suppression of activity in the first hour of the three-hour light pulse (Fig. 1B). Thus, the current results on controlled genetic backgrounds show substantially less penetrance and expressivity than originally reported (18% versus 80% penetrance) [3].
Table 1

Activity measurements at 200–300 lux

Mouse number



Total activitya

Daytime activityb



























B6.129 F1






B6.129 F1




























































B6.129 F1






B6.129 F1





a Average number of wheel revolutions per twenty-four hour period.

b Percentage of total wheel revolutions during light cycle.

c Percent suppression of activity during three-hour light pulse given during the dark cycle, relative to activity in the same dark cycle time period on the previous day.

Figure 1

Locomotor activity in Egfr wa2/wa2 mice during 12 h:12 h light:dark cycles and three-hour light pulses given during the dark cycle. Horizontal white and black bars represent light and dark exposure, respectively. Vertical axis indicates wheel-running activity. (A) The majority of Egfr wa2/wa2 mice tested were indistinguishable from wildtype controls in behavior, though two Egfr wa2/wa2 mice did exhibit a phase shift resulting in abnormally high daytime activity, as well as abnormally high activity during a three hour light pulse. (B) Abnormal wheel running activity during three-hour light pulses followed a characteristic one-hour of activity suppression in three Egfr wa2/wa2 mice (red), while wildtype (dark blue) and the majority of Egfr wa2/wa2 mice (light blue) demonstrated suppression of activity throughout the pulse. Grey areas, lights off; white area, light pulse.

The discrepancy between previous results using the B6EiC3H mixed genetic background and our current results with congenic mice is particularly surprising since most abnormal phenotypes increase in severity with inbreeding, this being particularly striking for phenotypes associated with Egfr [1, 12]. However, use of the B6EiC3H-a/A-Egfr wa2 Wnt3a vt stock to study effects of the Egfr wa2 allele is immediately problematic since Egfr wa2 homozygotes are also homozygous for the linked Wnt3a vt mutation, a hypomorphic allele of Wnt3a known for producing the vestigial tail phenotype [13]. Since Wnt3a-deficient mice exhibit defects in the hippocampus and central nervous system [14], the Wnt3a vt allele is possibly responsible for the activity defects. Additionally, the non-inbred B6EiC3H background, maintained through a cross-outcross mating scheme, harboring the Egfr wa2 and Wnt3a vt alleles in cis segregates known and unknown mutations from the C57BL/6JEi and C3H/HeSnJ strains [15]. Consequently, defects like those previously reported for locomotor activity cannot be attributed to Egfr because an appropriate control does not exist for the mixed B6EiC3H background.

Wildtype inbred mice from the C57BL/6JEi and C3H/HeSnJ strains have different masking thresholds and vary in diurnal locomotor activity in a manner that is likely multigenic [16, 17]. One strong candidate for such a modifier mutation is retinal degeneration (Pdeb rd1), which is carried by the C3H/HeSnJ strain but not C57BL/6EiJ, and causes progressive and selective degeneration of photoreceptor cells [18, 19]; the Pdeb rd1 mutation alone has a highly significant effect on masking behavior [16]. Melatonin production is also vastly different between the two strains contributing to the B6EiC3H mixed background, with C3H mice exhibiting high, rhythmic melatonin levels, and C57BL/6 mice exhibiting low to undetectable melatonin levels caused by mutation of at least one gene (N-acetyltransferase 2) related to melatonin production [20, 21]. The previous Egfr wa2 homozygous cohort that had a high penetrance of activity defects may have fortuitously contained a high frequency of these or other genetic modifiers given the small number of individuals tested.

Previous studies utilizing direct infusion of ligand to hyperactivate EGFR in the brain have shown that abnormally high EGFR signaling is capable of perturbing light-associated locomotor activity control [3, 6]. However, such an approach can produce non-physiological responses that are artifactual or neomorphic in nature rather than being representative of normal biology [7]. Thus, the suggestion that locomotor activity is strongly dependent on normal levels of EGFR signaling is not supported, especially since extensive testing of B6EiC3H-a/A Egfr wa2/wa2 Wnt3a vt/vt mice across a wide range of lighting conditions failed to detect any differences in masking response [11]. Using appropriately controlled genetic conditions, our results conclusively demonstrate that EGFR activity is not required to produce and is not a major mediator of abnormal activity phenotypes, and that other environmental, genetic, or stochastic effects are required to reveal abnormal phenotypes. A recent report revealed significant intrastrain and intraindividual fluctuations of EGFR ligand levels in the SCN of inbred mice [2]. Thus we cannot eliminate the possibility that homozygosity for Egfr wa2 may cause individuals to be sensitized to phenotypically express abnormal locomotor activities. For example, Egfr wa2 homozygotes have variable eye defects [8] that could combine with other factors to contribute to light-associated activity abnormalities. In fact one of the Egfr wa2/wa2 individuals in our study supports the presence of intraindividual variability, exhibiting an abnormal masking response in one trial followed by a near-normal response in a subsequent trial (data not shown).


The mice used to originally implicate EGFR as a major mediator of locomotor activity carried numerous other mutations and allelic variants that could contribute to the observed results. Since the animals were not properly controlled for genetic background, numerous other interpretations (such as unequal genetic background distribution in control and test mice) most likely contributed to the erroneous results. Our data using genetically uniform congenic lines indicate that EGFR is not a required mediator of the locomotor or masking behaviors, though it may modulate the activity of other pathways involved in control of locomotor activity. Further investigation is required to properly elucidate the molecular pathways and factors mediating locomotor activity.



This work was supported by grants from the National Institutes of Health (CA092479 and HD039896) to DWT and (GM031082) to AS.

Authors’ Affiliations

Department of Genetics, CB 7264, University of North Carolina at Chapel Hill, Chapel Hill, USA
Department of Biochemistry, CB 7260, University of North Carolina at Chapel Hill, Chapel Hill, USA


  1. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ, Magnuson T: Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 1995, 269:230–234.View ArticlePubMedGoogle Scholar
  2. Van der Zee EA, Roman V, Ten Brinke O, Meerlo P: TGFalpha and AVP in the mouse suprachiasmatic nucleus: anatomical relationship and daily profiles. Brain Res 2005,1054(2):159–166.View ArticlePubMedGoogle Scholar
  3. Kramer A, Yang FC, Snodgrass P, Li X, Scammell TE, Davis FC, Weitz CJ: Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling. Science 2001,294(5551):2511–2515.View ArticlePubMedGoogle Scholar
  4. Zak DE, Hao H, Vadigepalli R, Miller GM, Ogunnaike BA, Schwaber J: Systems analysis of circadian time-dependent neuronal epidermal growth factor receptor signaling. Genome Biol 2006, 7:R48.1–15.View ArticleGoogle Scholar
  5. Saper CB, Scammell TE, Lu J: Hypothalamic regulation of sleep and circadian rhythms. Nature 2005, 437:1257–1263.View ArticlePubMedGoogle Scholar
  6. Snodgrass-Belt P, Gilbert JL, Davis FC: Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters. Brain Research 2005, 1038:171–182.View ArticlePubMedGoogle Scholar
  7. Wakefield LM, Yang Y, Dukhanina O: Transforming growth factor-beta and breast cancer: essons learned from genetically altered mouse models. Breast Cancer Research 2000, 2:100–106.View ArticlePubMedGoogle Scholar
  8. Luetteke NC, Phillips HK, Qiu T, Copeland NG, Earp HS, Jenkins NA, Lee DC: The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes and Development 1994, 8:399–413.View ArticlePubMedGoogle Scholar
  9. Fowler KJ, Walker F, Alexander W, Hibbs ML, Nice EC, Bohmer RM, Mann GB, Thumbwood C, Maglitto R, Danks JA, Chetty R, Burgess AW, Dunn AR: A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on the receptor biochemistry that results in impaired lactation. Proceedings of the National Academy of Sciences USA 1995, 92:1465–1469.View ArticleGoogle Scholar
  10. Sibilia M, Wagner EF: Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 1995, 269:234–238.View ArticlePubMedGoogle Scholar
  11. Mrosovsky N, Redlin U, Roberts RB, Threadgill DW: Masking in waved-2 mice: Egf receptor control of locomotion quesitoned. Chronobiol Int 2005, 22:963–974.View ArticlePubMedGoogle Scholar
  12. Strunk KE, Amann V, Threadgill DW: Phenotypic variation resulting from a deficiency of epidermal growth factor receptor in mice is caused by extensive genetic heterogeneity that can be genetically and molecularly partitioned. Genetics 2004, 167:1821–1832.View ArticlePubMedGoogle Scholar
  13. Greco TL, Takada S, Newhouse MM, McMahon JA, McMahon AP, Camper SA: Analysis of the vestigial tail mutation demonstrates that Wnt-3a gene dosage regulates mouse axial devleopment. Genes and Development 1996, 10:313–324.View ArticlePubMedGoogle Scholar
  14. Lee SM, Tole S, Grove E, McMahon AP: A local Wnt-3a signal is required for development of the mammalian hippocampus. Development 2000, 127:457–467.PubMedGoogle Scholar
  15. Staff: Genetic background effects: can your mice see? JAX Notes Bar Harbor , Jackson Laboratory 2002.Google Scholar
  16. Mrosovsky N, Foster RG, Salmon PA: Thresholds for masking responses to light in three strains of retinally degenerate mice. J Comp Physiol [A] 1999,184(4):423–428.View ArticleGoogle Scholar
  17. Tankersley CG, Irizarry R, Flanders S, Rabold R: Circadian rhythm variation in activity, body temperature, and heart rate between C3H/HeJ and C57BL/6J inbred strains. J Appl Physiol 2002,92(2):870–877.View ArticlePubMedGoogle Scholar
  18. White JA, Burgess BJ, Hall RD, Nadol JB: Pattern of degeneration of the spiral ganglion cell and its processes in the C57BL/6J mouse. Hear Res 2000,141(1–2):12–18.View ArticlePubMedGoogle Scholar
  19. Wang S, Villegas-Perez MP, Vidal-Sanz M, Lund RD: Progressive optic axon dystrophy and vacuslar changes in rd mice. Invest Ophthalmol Vis Sci 2000,41(2):537–545.PubMedGoogle Scholar
  20. Ebihara S, Marks T, Hudson DJ, Menaker M: Genetic control of melatonin synthesis in the pineal gland of the mouse. Science 1986,231(4737):491–493.View ArticlePubMedGoogle Scholar
  21. Vivien-Roels B, Malan A, Rettori MC, Delagrange P, Jeanniot JP, Pevet P: Daily variations in pineal melatonin concentrations in inbred and outbred mice. J Biol Rhythms 1998,13(5):403–409.View ArticlePubMedGoogle Scholar


© Roberts et al. 2006

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.